Screener
Bioventus BVS Receipt of deferred consideration
Receipt of deferred consideration at other companies
Other financials
Where this comes from
Reported directly by Bioventus in its filing.
Tagged under the XBRL concept bvs:ProceedsFormDeferredConsideration.
The source filing: Bioventus’s 10-K, filed March 5, 2026. Open the filing →
- Filed
- Mar 5, 2026, 7:37 AM EST
- Fiscal year
- FY2025
- Accession
- 0001665988-26-000011
FAQ
- What is Bioventus's receipt of deferred consideration?
- Bioventus (BVS) reported receipt of deferred consideration of $0 in Q4 2025.
- How has Bioventus's receipt of deferred consideration changed year-over-year?
- Bioventus's receipt of deferred consideration decreased by 100.0% year-over-year, from $1.13M to $0.
- What does receipt of deferred consideration mean?
- Receipt of deferred consideration as reported by Bioventus Inc. Class A Common Stock.
Ask your AI about Bioventus's receipt of deferred consideration.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude